Reducing Steroidal Glycoalkaloids in Solanaceous Crops via Gene Editing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Solanaceous crop plants contain significant amounts of antinutritional steroidal glycoalkaloids, which are toxic to humans and reduce the nutritional quality of food, while also lacking desirable phytosterols like cholesterol, posing challenges in food production and safety.
Innovation Solution
Genetically modified or gene-edited plants with altered expression of specific genes, such as those encoding cellulose synthase-like proteins, are developed to reduce steroidal alkaloid content and increase phytosterol levels, using techniques like CRISPR/CAS systems to modify gene expression and produce plants with reduced toxic compounds and elevated beneficial sterols.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If plants produce steroidal alkaloids for natural defense, then pathogen resistance is improved, but toxic effects on humans and nutritional quality deteriorate
Solution Approach 1:
The patent applies local quality by differentiating the distribution and concentration of steroidal alkaloids in different plant tissues. By targeting specific genes (GAME1, GAME2, GAME3, GAME4) responsible for SGA accumulation, the invention reduces toxic glycoalkaloid levels in edible portions while potentially maintaining defensive functions in non-edible parts. This spatial differentiation allows the plant to maintain pathogen resistance where needed while minimizing human exposure to toxins.
Solution Approach 2:
The patent employs parameter changes by modifying the expression levels of key biosynthetic genes to alter the quantity and composition of steroidal alkaloids. Through genetic modification (down-regulation or silencing of GAME genes), the concentration of toxic SGAs is reduced to safe levels while the plant's overall defensive capability is preserved through balanced modulation of the alkaloid profile.
2Object-affected harmful factors
If steroidal alkaloids are reduced for food safety, then nutritional quality is improved, but plant defense capability deteriorates
Solution Approach 1:
The patent uses parameter changes to precisely control the expression levels of steroidal alkaloid biosynthetic genes. By partially down-regulating rather than completely eliminating GAME gene expression, the invention achieves a balanced state where SGA levels are reduced to safe concentrations for human consumption while sufficient alkaloid levels remain to provide effective pathogen defense.
Solution Approach 2:
The patent applies partial action by selectively reducing only the toxic glycoalkaloid fraction through targeted gene modification, while maintaining or preserving other protective secondary metabolites. This partial modification approach ensures food safety is improved without completely compromising the plant's defense system.
3Object-affected harmful factors
If genetic modification techniques are used to alter steroidal alkaloid content, then food safety and nutritional quality are improved, but device complexity and regulatory challenges increase
Solution Approach 1:
The patent extracts and targets specific key genes (GAME1, GAME2, GAME3, GAME4) from the complex steroidal alkaloid biosynthetic pathway for modification. By focusing on these critical regulatory genes rather than attempting to modify the entire pathway, the invention simplifies the genetic modification process while achieving effective reduction of toxic SGAs.
Solution Approach 2:
The patent uses RNA interference (RNAi) as an intermediary mechanism to down-regulate GAME gene expression. This molecular intermediary approach allows for controlled and reversible reduction of steroidal alkaloid biosynthesis, providing a manageable and regulatable method compared to direct gene knockout or overexpression strategies.
Data Source
AI summary
The present invention relates to key genes in the biosynthesis of steroidal alkaloids and saponins, including regulatory genes and enzyme-encoding genes, and to use thereof for altering the content of steroidal (glyco)alkaloids or phytosterols in plants. The present invention provides genetically modified plants or gene edited plants with altered content of steroidal (glyco)alkaloids, particularly to Solanaceous crop plants with reduced content of antinutritional steroidal glycoalkaloids and to the increase in phytosterols, including cholesterol or cholestanol in these plants. The present invention also provides methods of altering gene expression.